EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+11.07%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.1B
AUM Growth
-$1.95B
(-64%)
Cap. Flow
-$2.1B
Cap. Flow
% of AUM
-190.3%
Top 10 Holdings %
Top 10 Hldgs %
55.43%
Holding
359
New
34
Increased
188
Reduced
93
Closed
36
Top Buys
| 1 |
STAAR Surgical
STAA
|
$42.6M |
| 2 |
Sea Limited
SE
|
$22.9M |
| 3 |
Mercado Libre
MELI
|
$19.7M |
| 4 |
NIO
NIO
|
$19.6M |
| 5 |
Meta Platforms (Facebook)
META
|
$16.1M |
Top Sells
| 1 |
Alibaba
BABA
|
$1.32B |
| 2 |
JD.com
JD
|
$334M |
| 3 |
Baidu
BIDU
|
$314M |
| 4 |
NetEase
NTES
|
$202M |
| 5 |
Trip.com Group
TCOM
|
$95M |
Sector Composition
| 1 | Consumer Discretionary | 35.58% |
| 2 | Technology | 17.59% |
| 3 | Communication Services | 16.9% |
| 4 | Healthcare | 11.23% |
| 5 | Real Estate | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
226
Baidu
BIDU
$35.1B
| $307K | 0.03% |
2,064
-2,109,040
| -100% | -$314M |
|
227
Align Technology
ALGN
$10.1B
| $304K | 0.03% |
1,286
+115
| +10% | +$27.2K |
|
228
Philip Morris
PM
$251B
| $304K | 0.03% |
3,078
+41
| +1% | +$4.05K |
|
229
Agios Pharmaceuticals
AGIO
$2.09B
| $303K | 0.03% |
13,673
+4,750
| +53% | +$105K |
|
230
NextEra Energy, Inc.
NEE
$146B
| $302K | 0.03% |
3,901
+73
| +2% | +$5.65K |
|
|
CTIC
231
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $300K | 0.03% |
+50,171
| New | +$300K |
|
232
Enanta Pharmaceuticals
ENTA
$189M
| $299K | 0.03% |
6,320
+3,430
| +119% | +$162K |
|
233
Skyworks Solutions
SWKS
$11.2B
| $299K | 0.03% |
3,225
-48
| -1% | -$4.45K |
|
234
AT&T
T
$212B
| $298K | 0.03% |
14,215
-4,227
| -23% | -$88.6K |
|
235
TG Therapeutics
TGTX
$5.11B
| $298K | 0.03% |
70,105
+39,622
| +130% | +$168K |
|
236
Wells Fargo
WFC
$253B
| $295K | 0.03% |
7,526
-252
| -3% | -$9.88K |
|
237
Copart
CPRT
$47B
| $293K | 0.03% |
10,772
+308
| +3% | +$8.38K |
|
238
Inovio Pharmaceuticals
INO
$148M
| $290K | 0.03% |
13,956
+7,014
| +101% | +$146K |
|
239
Vericel Corp
VCEL
$1.72B
| $289K | 0.03% |
11,497
+5,228
| +83% | +$131K |
|
240
Linde
LIN
$220B
| $288K | 0.03% |
1,000
| – | – |
|
241
Ligand Pharmaceuticals
LGND
$3.25B
| $287K | 0.03% |
5,163
+1,317
| +34% | +$73.2K |
|
242
Allogene Therapeutics
ALLO
$255M
| $285K | 0.03% |
25,006
-3,309
| -12% | -$37.7K |
|
243
Protagonist Therapeutics
PTGX
$3.77B
| $285K | 0.03% |
36,033
+25,593
| +245% | +$202K |
|
244
Ross Stores
ROST
$49.4B
| $284K | 0.03% |
4,049
+51
| +1% | +$3.58K |
|
245
RTX Corp
RTX
$211B
| $284K | 0.03% |
2,953
+33
| +1% | +$3.17K |
|
246
Enphase Energy
ENPH
$5.18B
| $278K | 0.03% |
1,422
-5
| -0.4% | -$977 |
|
247
Carnival Corp
CCL
$42.8B
| $277K | 0.03% |
32,016
+14,407
| +82% | +$125K |
|
248
Lucid Motors
LCID
$5.66B
| $273K | 0.02% |
1,593
+45
| +3% | +$7.71K |
|
249
Sana Biotechnology
SANA
$752M
| $273K | 0.02% |
42,452
+18,124
| +74% | +$117K |
|
250
Cigna
CI
$81.5B
| $269K | 0.02% |
1,021
-100
| -9% | -$26.3K |
|